If you are:
FDB Contraindicated or Not Recommended: FETAL DEATH/MORBIDITY W/USE IN 2ND & 3RD TRIMESTER, STOP WHEN PREGNANCY DETECTED
Precaution: CAUTION ADVISED; SERIOUS ADVERSE EFFECTS POSSIBLE
Giving aliskiren tablet to a child under 12:
management or monitoring precaution: Potential risk of increased drug exposure and toxicity. Safety and efficacy not established in pediatrics.